GIORGI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 7.055
EU - Europa 3.992
AS - Asia 1.679
AF - Africa 145
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
Totale 12.905
Nazione #
US - Stati Uniti d'America 6.809
IT - Italia 1.486
SE - Svezia 728
CN - Cina 631
DE - Germania 509
VN - Vietnam 426
BG - Bulgaria 338
CA - Canada 245
GB - Regno Unito 235
SG - Singapore 212
TR - Turchia 206
UA - Ucraina 183
FI - Finlandia 153
CH - Svizzera 93
CI - Costa d'Avorio 76
IN - India 73
HK - Hong Kong 68
RU - Federazione Russa 56
GR - Grecia 55
FR - Francia 50
AT - Austria 41
NG - Nigeria 37
BE - Belgio 27
KR - Corea 26
SN - Senegal 19
IR - Iran 18
BR - Brasile 12
NL - Olanda 11
EU - Europa 9
MA - Marocco 9
JP - Giappone 8
AU - Australia 7
PL - Polonia 6
ES - Italia 4
DK - Danimarca 3
EE - Estonia 3
IE - Irlanda 3
PH - Filippine 3
YE - Yemen 3
HU - Ungheria 2
NZ - Nuova Zelanda 2
AR - Argentina 1
BN - Brunei Darussalam 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
IS - Islanda 1
LV - Lettonia 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 12.905
Città #
Woodbridge 1.170
Ann Arbor 1.007
Houston 759
Milan 756
Chandler 700
Fairfield 426
Dong Ket 391
Sofia 338
Beijing 248
Jacksonville 239
Ashburn 238
Ottawa 203
Wilmington 201
Cambridge 171
Izmir 171
Seattle 171
Chicago 153
New York 140
Boardman 132
Princeton 127
Lawrence 117
Medford 110
Nanjing 108
Bern 93
Abidjan 76
Des Moines 66
Hong Kong 66
Jüchen 63
Singapore 59
Alessandria 56
London 54
Serra 54
Dearborn 53
Rome 52
Florence 51
Boulder 40
Bremen 40
Nanchang 38
Lagos 37
Los Angeles 35
Vienna 35
Redwood City 33
Marseille 32
Ogden 32
Lancaster 31
Kocaeli 29
Sacile 29
Hyderabad 28
Brussels 26
North York 26
San Diego 26
Shenyang 25
Kunming 24
Helsinki 22
Pune 22
Dakar 19
Hebei 19
Grafing 18
Düsseldorf 17
Frankfurt am Main 17
Jiaxing 17
Tianjin 15
Verona 15
Falls Church 14
Hefei 14
Guangzhou 13
Changsha 12
Hangzhou 12
Nürnberg 12
Tabriz 12
Norwalk 11
Berlin 9
Orange 8
Philadelphia 8
Auburn Hills 7
Ningbo 7
Shanghai 7
Detroit 6
Guangdong 6
Indiana 6
Jinan 6
Lanzhou 6
Washington 6
Dallas 5
Moscow 5
Munich 5
Pisa 5
Redmond 5
San Francisco 5
Fuzhou 4
Harbin 4
Lappeenranta 4
Nuremberg 4
Phoenix 4
Tokyo 4
Toronto 4
Babol 3
Borås 3
Canberra 3
Changchun 3
Totale 9.818
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 265
1,2,3 Triazolo[1,2-a]benzotriazoles or 2,3-Benzo-1,3a,6,6a-Tetraazapentalenes 239
1,2,3-Triazolo[1,5-a][1,3]benzodiazepine a new heterocyclic system: Synthesis, benzodiazepine receptor binding and theoretical calculations 236
1,2,3-Triazole[4,5-d]pyridazines II. New Derivatives Tested on the Adenosine Receptors 226
An 1,2,3-Triazole Derivative Bioisoster of a Potent in Vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 222
1,2,3-triazolo [4,5-d] pyridazines-V. Preparation and adenosine receptor binding of new 4-amino derivatives. 218
1,2,3-Triazolo[1,5-a][1,4]- and 1,2,3-Triazolo[1,5-a][1,5]benzodiazepine derivatives: synthesis and benzodiazepine receptor binding. 203
1,2,3-TRIAZOLE[4,5-D]PYRIDAZINES .3. SYNTHESIS OF NEW 4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARD ADENOSINE RECEPTORS 187
1,2,3-Triazolodiazepine I. Preparation and Benzodiazepine Receptor Binding of 1-Benzyl and 1-Phenethyl-1,2,3-Triazolo[4,5-d][1,4]diazepines 179
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 178
1,2,3-Triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors 176
1,2,3-Triazolo[4,5-d]-1,2,4-triazolo[4,3-b]pyridazines 175
1,2,3-TRIAZOLO[4,5-e]-1,2,4-TRIAZOLO[3,4-c]PYRIMIDINES 173
1,2,3-Triazole[4,5-d]pyridazines IV. Preparation and Adenosine Receptor Binding of New 4-and /or 7-Aminoderivatives 171
N(6)-SUBSTITUTED 2-PHENYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR - A COMPARISON WITH 2-N-BUTYL ANALOGOUS DERIVATIVES .5. 170
N(6)-SUBSTITUTED 2-N-BUTYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR .4. 165
1,2,3-triazolo[1.5-a]quinazolines: synthesis, benzodiazepine receptor binding and theoretical calculations 157
1,2,3-triazolo[4,5-d]pyridazines - Part VI. New 1-substituted-4-amino derivatives and their affinity towards A(1) and A(2A) adenosine receptors 157
N(6)-Substituted 2-n-Butyl-9-Benzyl-8-Azaadenines. Affinity for Adenosine A1 and A2 Receptors. IV 154
Novel 8-azapurine derivatives as ligands for A3 adenosine receptors 154
"One Pot" Synthesis of 2-Substituted 9-(2'-Hydroxy-3'-aminopropyl)-8-azahypoxanthines and 8-Azaadenines [5-Substituted 3-(2'-Hydroxy-3'-aminopropyl)-7-amino and 7-hyroxy- 3H-1,2,3-triazolo[4,5-d]pyrimidines] 153
1,2,3-TRIAZOLO[4,5-D]PYRIDAZINES. PART VI. NEW 1-SUBSTITUTED-4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARDS A1 AND A2 ADENOSINE RECEPTORS 148
N(6)-substituted 2-phenyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. A comparison with 2-N-butyl analogous derivatives.5. 148
Synthesis of New 3-Benzyl-5-Phenyl-7-Alkylaminothiazolo[4,5-d]pyrimidine-2(3H)-Thiones.) 145
N(6)CYCLOALKYL-2-PHENYL-3-DEAZA-8-AZAADENINES: A NEW CLASS OF A1ADENOSINE RECEPTOR LIGANDS. A COMPARISON WITH THE CORRESPONDING ADENINES AND 8-AZAADENINES 145
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 141
2-Fenyl-9-benzyl-6-arylamido-8-azapurines: new potent ligands of adenosine receptors 137
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 137
NEW 1,2,3-TRIAZOLO[1,5-a]QUINOXALINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS. II 135
1,2,3-Trizoles[4,5-d]piridazines. Analogues of Prostaglandin Synthesis Inhibitors 130
N-[9-(ortho-Fluorobenzyl)-2-Phenyl-8-Azapurin-6-yl]-Amides as Potent and Selective Ligands for A1 Adenosine Receptors. 128
N(6) or N(9) Substituted 2-Phenyl-8-Azaadenines: Affinity for A1 Adenosine Receptors. VII 125
1-(1,2,3-TRIAZOL-4-YL)-BENZIMIDAZOLONES, A NEW SERIES OF HETEROCYCLIC DERIVATIVES 125
5-(4'-SUBSTITUTED-2'-NITROANILINO)-1,2,3-TRIAZOLES AS NEW POTENTIAL POTASSIUM CHANNEL ACTIVATORS. I 124
Adenosine A1 modulators: a patent update (2008 to present) 124
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 123
2,9-Disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: Synthesis, biochemical and molecular modelling studies 123
N-(9-Benzyl-2-phenyl-9H-8azapurin-6-yl)-amides: A new class of A1 adenosine receptor ligands 119
Xanthine Oxidase (XO). 4(5)-Aminosubstituted-5(4)-Carboxyamido-1H-1,2,3-Triazoles: a New Class of Monocyclic Triazole Inhibitors 118
N(9)-substituted 2-phenyl-N(6)-benzyl-8-azaadenines: A1 adenosine receptor affinity. A comparison with the corresponding N(6)-substituted 2-phenyl-N(9)-benzyl-8-azaadenines 118
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 116
3-[(2-Ethoxyphenoxy)methyl]piperidine derivatives. Synthesis and antidepressant activity 116
8-Azapurine nucleus: a versatile scaffold for different targets 114
ERYTHRO AND THREO 2-HYDROXYNONYL SUBSTITUTED 2-PHENYLADENINES AND 2-PHENYL-8-AZAADENINES: LIGANDS FOR A1 ADENOSINE RECEPTORS AND ADENOSINE DEAMINASE 114
A QSAR study of A1adenosine receptor antagonists by a new neural network model 112
Studies on Specific Inhibition of Benzodiazepine Receptor Binding by Some C-Benzoyl-1,2,3-triazole Derivatives 112
Xanthine Oxidase Inhibition: Effect of a Linear Carboalkoxy Substituent on C(2) of the Nucleus of 8-Azahypoxanthine 110
Studies on 1,2,3-Triazole Derivatives as in vitro Inhibitors of Prostaglandine Synthesis 110
New 4-(Benzotriazol-1-yl)-1,2,3-triazole derivatives 108
Antimicrobial properties of flavonoids. 107
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 107
TRIAZOLYLBENZIMIDAZOLTHIONES AND DERIVATIVES OF THE NEW 1,2,3-TRIAZOLO[1,5-A][1,3,5]BENZOTRIAZEPINE HETEROCYCLE 106
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 106
In vitro Inhibitors of Prostaglandin Synthesis: (p-Thiosubstituted)-Benzyl Nitrogen Heterocycles 105
New amido derivatives as potential BKCa potassium channel activators. XI 105
QSAR study on purine and 2,3-dihydropurine analogues as antitubercular agents 104
Introduction of a hydroxy function on N6 8-azaadenine substituents to improve the solubility and the effectiveness of antagonists towards A1 adenosine receptors 103
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 102
Bioisosterism, enantioselectivity and molecular modeling of new effective N6- and/or N(9)-substituted 2-phenyl adenines and 8-aza analogs: different binding modes to A1 adenosine receptors 102
Synthesis of New 2-Substituted 9-?-D-Ribofuranosyl-8-Azahypoxanthine 101
XANTHINE-OXIDASE (XO) - RELATIVE CONFIGURATION OF COMPLEXES FORMED BY THE ENZYME, 2-N-ALKYL-HYPOXANTHINE OR 8-N-ALKYL-HYPOXANTHINE AND 2-N-ALKYL-8-AZAHYPOXANTHINES .12. 101
Synthesis of New 1,2,3-triazolo[1,2-a]benzotriazole derivatives or substituted 2,3-benzo-1,3a,6,6a-tetraazapentalenes. II” 101
Interaction of an improved model of human A1 adenosine receptor with ligands 99
Modification of the 1,2,3-Triazole Ring Present in an Effective in vitro Inhibitor of Prostaglandin Synthesis 97
Evaluation of the Quantitative Contribution of a Phenyl Group on C(2) of 8-Azaadenosine to the Binding with Adenosine Deaminase: a New Synthesis of 8-Azaadenosine. XI. 96
THERAPEUTIC POTENTIAL OF A1 ADENOSINE RECEPTOR LIGANDS: A SURVEY OF RECENT PATENT LITERATURE 95
QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists 95
Structure-Activity Studies on a 1,2,3-Triazole Derivative, a Potent in vitro Inhibitor of Prostaglandin Synthesys: the Role of the Heterocyclic Ring 94
SUBSTITUTED 1,2,3-TRIAZOLO[1,5-A]QUINAZOLINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS 94
An initial comparison of the content of bitter substances in Cynara Scolymus L. plants obtained from rooted of shoots and micropropagation 94
A 3D model of human A1 adenosine receptor. An evaluation of the binding free energy with ligands 93
Synthesis of N(6)-Substituted 2-Phenyl-8-Azaadenosines. Their Affinity for Adenosine A1 and A2 Receptors: a Comparison with the Corresponding 2-Phenyl-9-Benzyl-8-Azaadenines. 92
2-ALKYLOXYALKYLTHIOHYPOXANTHINES AS NEW POTENT INHIBITORS OF XANTHINE OXIDASE 92
THE NEW DEGREE IN TECHICHE ERBORISTICHE (HERBAL TECHNOLOGY) 91
NEW 1,2,3-TRIAZOLO[4,5-E]1,2,3-TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES.II 91
SOME STRUCTURAL CHANGES ON TRIAZOLYL-BENZOTRIAZOLES AND TRIAZOLYL-BENZIMIDAZOLONES AS POTENTIAL POTASSIUM CHANNEL ACTIVATORS. III 90
Heterocyclic analogs of benzanilide derivatives as potassium channel activators. IX 87
Xanthine Oxidase (XO). Synthesis of 4(5)-Carbxyamido-5(4)-aminoalkanoyl)amino-1,2,3-triazoles and Their Cyclization to 8-Azahypoxanthines. Evaluation for Inhibition of XO. 85
Synthesis and Biological Evaluation of New Imidazole, Pyrimidine and Purine Derivatives and Analogs as Inhibitors of Xanthine Oxidase 83
Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. II 83
An 1,2,3,Triazole Derivatives Bioisoster of a Potent in vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 82
Xanthine Oxidase (XO): Relative Configuration of Complexes Formed by the Enzyme, 2- or 8-n-Alkyl-hypoxanthines and 2-n-Alkyl-8-azahypoxanthines. XII 82
QSAR Studies on Purine and 2,3-Dihydropurine Analogues as Antitubercular Agents 82
New Chiral Inhibitors of Induced Platelet Aggregation: the Enantiomeric Specificity of (R)- and (S)-Methyl and Ethyl Esters of 1-{p-[(1-Hydroxycarbonyl)-ethyloxy]-benzyl}-1H-1,2,3-triazole as a Tool for Determining their Biological Target. 79
Steroeselectivity as an evidence for a double insertion of Antagonists within A1 Adenosine Receptors 79
Chemistry of the Dihydrothiazine Ring Moiety of Cephalosporins. A Route to 3-Formoxymethyl-3-Cephem Derivatives 79
Structural modifications of benzanilide derivatives, effective potassium channel openers. X 78
Synthesis and ADA Inhibitory Activity of New 2-Aryl-8-Azaadenosines 76
Synthesis of analogs of (±)-EHNA as potent inhibitors of ADA 76
Interconversion of the thiazine and thiazolidine system of β -lactam antibiotics. Electrochemical cleavage of Kamiya's disulfide promoted by bromide ion 76
1,5-Diarylsubstituted 1,2,3-triazoles as potential potassium channels activators. VI. 75
A Method for the Synthesis of Racemic and Optically Active 2-Substituted 9-(2',3'-Dihidroxypropyl)-8-Azahypoxanthines and 8-Azaadenines 74
Interactions of an improved model of the the Human A1 Adenosine Receptor with Ligands 74
NEW N6-OR N(9)-HYDROXYALKYL SUBSTITUTED 8-AZAADENINES OR ADENINES AS AFFECTIVE A1 ADENOSINE RECEPTOR LIGANDS 74
Synthesis and functional evaluation of Adenosine A2A receptor ligand 70
Importance of the Substituent on C(2) in the Interconversion of the Thiazine and the Thiazolidine System of b-Lactam Antibiotics 69
A 3D Model of the Human A1 Adenosine Receptor. An Evaluation of the Binding Free-Energy with Ligands 69
New amino derivatives of 1,2,3-triazolo[4,5-D]pyrimidines and their affinity towards A1 and A2A adenosune receptors 67
Synthesis of new 2-phenyladenines and 2-phenylpteridines and biological evaluation as adenosine receptor ligands 66
XANTHINE-OXIDASE INHIBITION - EFFECT OF AN N-ALKYL SUBSTITUENT ON C-2 OF THE NUCLEUS OF 8-AZAHYPOXANTHINE 66
Totale 11.957
Categoria #
all - tutte 30.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.236 0 0 67 87 144 222 182 90 137 113 170 24
2020/20211.109 76 35 50 43 105 38 54 72 54 87 46 449
2021/20221.459 16 119 20 110 259 198 15 100 87 14 91 430
2022/20231.873 254 240 118 208 217 239 30 138 304 7 101 17
2023/20242.134 319 238 365 218 313 224 29 56 25 58 44 245
2024/2025192 46 146 0 0 0 0 0 0 0 0 0 0
Totale 12.971